SNCA and Parkinson disease: For instance, Hong, Chien-Tai et al. 2020 showed, in mice models, that IR-associated diabetes could promote PD progression via mitochondrial dysfunction, ROS overproduction, and enhanced SNCA signaling, leading to an increased α-synuclein production and subsequent aggregation [2].